Data Published in a Lancet Journal on COH04S1, a City of Hope-Developed COVID-19 Vaccine, Shows It Produced Robust Antibodies and T Cells Against SARS-CoV-2

March 10, 2022 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Data Published in a Lancet Journal on COH04S1, a City of Hope-Developed COVID-19 Vaccine, Shows It Produced Robust Antibodies and T Cells Against SARS-CoV-2

LOS ANGELES & ATLANTA–(BUSINESS WIRE)–COVID-19 investigational vaccine developed by City of Hope produced neutralizing antibodies and T cells with no major side effects in Phase 1 trial.